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INTRODUCTION
Every year there are a large number of 
venomous snake bites that occur around the 
world and especially in tropical areas. This is a 
problem that is faced worldwide with the 
World Health Organization classifying 
venomous snake bites as one of their highest 
priority neglected tropical diseases. One of the 
reasons for this classification is the short 
supply of antivenom compared to the number 
of snake envenomations that occurs each year. 
The standard of care for snake envenomation is 
administration of antivenom. Many antivenoms 
are polyvalent in that they are produced using 
venoms from multiple species of snakes. These 
polyvalent antivenoms can treat envenomation 
from the snake venoms that are used in the 
production, but also show cross-reactivity 
against snake venoms that share similar 
components. Determining the cross reactivities 
of antivenoms could help improve the quality 
of treatment, and provide a better 
understanding of venom-antivenom binding. 
Until recently there has only been one 
antivenom available for treatment of North 
American Crotaline envenomation. With the 
introduction of an F(ab’)2 antivenom 
(AnavipÒ)  into the United States, we look at 
the cross-reactivity of the western pygmy 
rattlesnake, Sistrurus miliarius streckeri (S. m. 
streckeri), against Anavip. 
METHODS
SE-HPLC was used to assess cross-reactivity. SE-
HPLC is a viable method to analyze antivenom-
venom reactivity based on separation of higher 
molecular weight complexes that form vs 
unreacted components. Estimates of venom-
antivenom reactivity was measured in reaction 
mixtures based on the increase in the elution 
profile area where higher molecular weight 
complexes are observed (region 1) and on the 
decrease in the elution profile area where 
reactants are observed (region 2). Reaction 
mixtures contained Anavip (1.0 mg/ml) and S. 
m. streckeri venom (0.125, 0.25, 0.5, or 1.0 
mg/ml). Controls were Anavip and S. m. 
streckeri  (1.0 & 0.5mg/ml). Mixtures were 
incubated at 37° C for 30 minutes, then stored 
at 4° C prior to SE-HPLC. 
Apparent saturation of reactive antivenom was 
observed at all venom concentrations. Estimates 
of Anavip reactivity with S. m. streckeri venom 
are seen in the changes of the elution profile 
region areas, showing the formation of larger 
molecular weight complexes and decrease in 
reactants. This shows that Anavip could provide 
protective effects against S. m. streckeri
envenomation. Further studies are needed to 
determine binding within a broader range of 
venom concentrations, as well as the 
composition of reactive and unreacted 
components. Results suggest that binding of 
Anavip to S. m. streckeri venom does occur, 
which is consistent with protective effects that 
are observed clinically. 
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Profile of control reactants taken at  AU 
214nm  shown on the left. Elution profiles 
divided into Regions 1, 2, & 3 to show 
changes in changes in composition between 
reactants and products. 
The graphs on the Left show elution profiles if 
no reaction had occurred and the elution 
profile of the reaction between Anavip and S. 
m. streckeri venom. Changes in the elution 
profile are seen in the reaction compared to 
the null, showing  cross-reactivity of Anavip to 
the venom. 
The difference elution profile shows the 
increase in Region 1  (immune complexes) 
and the decrease in the Region 2 (reactants). 
These changes were observed at all venom-
antivenom concentration.
The maximum venom-
antivenom binding was 
calculated, base on 
changes in the profile 
region areas, to be 
approximately 67% 
relative to the total area 
of the antivenom profile.
Decreases in the total profile areas are seen 
between the null profiles and reaction profiles. 
This is consistent with previous studies with 
F(ab’)2 antivenoms. We suspect this decrease in 
total profile area is due to the antivenom 
binding with multiple venom components 
creating high molecular weight immune 
complexes that do not enter the column (i.e. 
insoluble in elution buffer). Despite the 
decrease in the total profile areas we are still 
able to determine relative binding of Anavip and 
observe reactivity between Anavip and S. m. 
streckeri venom.
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